These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 1686941)
41. [Pleuropulmonary manifestations of rheumatoid arthritis]. Gayraud M; Guillevin L Ann Med Interne (Paris); 1990; 141(5):437-46. PubMed ID: 1979479 [No Abstract] [Full Text] [Related]
43. Bronchoalveolar lavage and lung biopsy in rheumatoid arthritis. In vivo effects of disease modifying antirheumatic drugs. Scherak O; Popp W; Kolarz G; Wottawa A; Ritschka L; Braun O J Rheumatol; 1993 Jun; 20(6):944-9. PubMed ID: 8102405 [TBL] [Abstract][Full Text] [Related]
44. Contemporary management of rheumatoid arthritis. Horwitz H; Conte J Med Health R I; 1999 Sep; 82(9):316-20. PubMed ID: 10517075 [No Abstract] [Full Text] [Related]
45. Cyclosporine and methotrexate for severe rheumatoid arthritis. Storb R; Thomas ED N Engl J Med; 1995 Dec; 333(23):1568; author reply 1568-9. PubMed ID: 7477182 [No Abstract] [Full Text] [Related]
46. A perspective on arthritis. Conn DL J Med Assoc Ga; 2002; 91(1):4-5. PubMed ID: 11938629 [No Abstract] [Full Text] [Related]
47. [Recent methods of drug therapy in rheumatoid arthritis]. Günther R Beitr Rheumatol; 1968; 13():75-87. PubMed ID: 5728436 [No Abstract] [Full Text] [Related]
48. New therapeutics in rheumatoid arthritis. Savage C; St Clair EW Rheum Dis Clin North Am; 2006 Feb; 32(1):57-74, viii. PubMed ID: 16504821 [TBL] [Abstract][Full Text] [Related]
49. Rheumatoid arthritis: new concepts in disease evolution, pathogenesis, and treatment. Paget SA Semin Arthroplasty; 1995 Jul; 6(3):132-44. PubMed ID: 10163520 [No Abstract] [Full Text] [Related]
50. Reduction of serum interleukin 7 levels upon methotrexate therapy in early rheumatoid arthritis correlates with disease suppression. van Roon JA; Jacobs K; Verstappen S; Bijlsma J; Lafeber F Ann Rheum Dis; 2008 Jul; 67(7):1054-5. PubMed ID: 18556451 [No Abstract] [Full Text] [Related]
52. [Actual results of the rheumatoid polyarthritis therapy with immuno-suppressive drugs: d-penicillamine and cytostatics (author's transl)]. Barnes CG Schweiz Rundsch Med Prax; 1977 Nov; 66(44):1412-20. PubMed ID: 928306 [No Abstract] [Full Text] [Related]
53. [Pharmacogenomics of the immunosuppressive agents]. Taniguchi A; Urano W; Tanaka E; Kitamura Y; Saito M; Akama H; Yamanak H; Saito T; Kamatani N Nihon Rinsho Meneki Gakkai Kaishi; 2002 Feb; 25(1):105-9. PubMed ID: 11963167 [No Abstract] [Full Text] [Related]
54. Thalidomide in the treatment of refractory rheumatoid arthritis. Keesal N; Wasserman MJ; Bookman A; Lapp V; Weber DA; Keystone EC J Rheumatol; 1999 Nov; 26(11):2344-7. PubMed ID: 10555888 [TBL] [Abstract][Full Text] [Related]
55. [Cytostatic therapy of rheumatoid arthritis]. Mäkisara P Duodecim; 1972; 88(8):563-5. PubMed ID: 5021189 [No Abstract] [Full Text] [Related]
56. [The effect of combined drug treatment using gold preparations on indices of lipid peroxidation in patients with rheumatoid arthritis]. Makarchuk OS Vrach Delo; 1990 Mar; (3):70-2. PubMed ID: 1973321 [TBL] [Abstract][Full Text] [Related]